The roster of elite athletes putting their name – and money – behind IM8 Health just got even more impressive.
NBA Champion and two-time MVP Giannis Antetokounmpo has been announced as a global partner and shareholder of IM8, making him the first NBA athlete to take equity in the NASDAQ-listed health and longevity brand.
Giannis Antetokounmpo Puts His Trust in IM8
“I’m very careful about what I put in my body and what I put my name on,” Giannis Antetokounmpo explained.
“When I looked at IM8, the clinical doses, the third-party testing, the real science behind every ingredient, I didn’t just want to endorse it. I believe in the product, and that’s exactly why I chose to invest in the company.”
In fact, Giannis took 100% equity over any cash compensation: a decision that speaks volumes about his belief in the brand.
He joins a partnership group that already includes co-founder David Beckham – who introduced him to the brand – world No.1 tennis player Aryna Sabalenka, and F1’s Ollie Bearman.
IM8 is set to continue its remarkable success
The brand itself – which only launched in December 2024 – has been on a remarkable trajectory over the last 18 months.
IM8 reached $100 million in annualised recurring revenue within just 11 months, with over 750,000 customer purchases across 31 countries. The company is projecting $180-200 million in revenue for 2026.
At the centre of it all is IM8’s flagship product, Daily Ultimate Essentials PRO, which contains 90 clinically-dosed ingredients in a single daily drink – replacing your entire supplement cupboard in one go.
It’s NSF Certified for Sport and backed by a 12-week clinical trial showing improvements across energy, digestion, sleep, and focus.
SEE ALSO: David Beckham’s IM8 Health “On Pace” to Becoming Fastest-Growing Supplement Brand In History
